Rubicon Organics Inc. (ROMJ.V)
CAD 0.4
(-1.25%)
CAD 0.4
(-1.25%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -1.82 Million CAD | 52.71% |
| 2022 | -3.85 Million CAD | 73.45% |
| 2021 | -14.52 Million CAD | 3.09% |
| 2020 | -14.98 Million CAD | -4.97% |
| 2019 | -14.27 Million CAD | 52.22% |
| 2018 | -29.87 Million CAD | -410.64% |
| 2017 | -5.85 Million CAD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -454.16 Thousand CAD | 76.0% |
| 2024 Q1 | -1.89 Million CAD | -471.62% |
| 2023 Q4 | 509.21 Thousand CAD | 130.98% |
| 2023 Q2 | -113.83 Thousand CAD | 80.2% |
| 2023 FY | -1.82 Million CAD | 52.71% |
| 2023 Q1 | -575.04 Thousand CAD | 81.79% |
| 2023 Q3 | -1.64 Million CAD | -1344.04% |
| 2022 Q2 | -1.23 Million CAD | 17.39% |
| 2022 Q3 | 2.02 Million CAD | 264.38% |
| 2022 FY | -3.85 Million CAD | 73.45% |
| 2022 Q1 | -1.49 Million CAD | 6.22% |
| 2022 Q4 | -3.15 Million CAD | -255.89% |
| 2021 FY | -14.52 Million CAD | 3.09% |
| 2021 Q4 | -1.59 Million CAD | 58.65% |
| 2021 Q3 | -3.84 Million CAD | 24.53% |
| 2021 Q2 | -5.09 Million CAD | -27.82% |
| 2021 Q1 | -3.98 Million CAD | 20.93% |
| 2020 Q3 | -4.31 Million CAD | -137.86% |
| 2020 Q2 | -1.81 Million CAD | 52.34% |
| 2020 FY | -14.98 Million CAD | -4.97% |
| 2020 Q1 | -3.8 Million CAD | 6.77% |
| 2020 Q4 | -5.04 Million CAD | -16.8% |
| 2019 FY | -14.27 Million CAD | 52.22% |
| 2019 Q4 | -4.08 Million CAD | 8.3% |
| 2019 Q3 | -4.45 Million CAD | -28.82% |
| 2019 Q2 | -3.45 Million CAD | -51.88% |
| 2019 Q1 | -2.27 Million CAD | 51.28% |
| 2018 Q4 | -4.67 Million CAD | -33.35% |
| 2018 FY | -29.87 Million CAD | -410.64% |
| 2018 Q1 | -2.57 Million CAD | -44.49% |
| 2018 Q2 | -18.17 Million CAD | -606.65% |
| 2018 Q3 | -3.5 Million CAD | 80.72% |
| 2017 FY | -5.85 Million CAD | 0.0% |
| 2017 Q4 | -1.78 Million CAD | -49.98% |
| 2017 Q3 | -1.18 Million CAD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Aequus Pharmaceuticals Inc. | -2.96 Million CAD | 38.492% |
| CanadaBis Capital Inc. | 4.44 Million CAD | 141.029% |
| Decibel Cannabis Company Inc. | -1.77 Million CAD | -3.025% |
| Delivra Health Brands Inc. | 876 Thousand CAD | 308.166% |
| Entourage Health Corp. | -46.16 Million CAD | 96.05% |
| Lifeist Wellness Inc. | -14.12 Million CAD | 87.091% |
| Cannara Biotech Inc. | 6.94 Million CAD | 126.255% |
| Medicure Inc. | -922 Thousand CAD | -97.78% |
| PharmaCielo Ltd. | -16.29 Million CAD | 88.811% |
| BioSyent Inc. | 6.46 Million CAD | 128.228% |
| Voyageur Pharmaceuticals Ltd. | -1.39 Million CAD | -30.302% |